Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 412272 in experimental congestive heart failure
The peptide's muscle-protective properties extend beyond genetic muscle diseases, with potential applications in preventing exercise-induced muscle damage, accelerating recovery from injury, and maintaining muscle mass during periods of disuse or immobilization
We systematically reviewed research on MNM-based therapies for specific conditions, including peptic ulcers, IBD, PC, CRC, and diabetes, integrated progress across these diseases, and discussed the potential clinical translation of MNMs
However, the glutamine switch mechanism assumes that the -NH 2 group of conserved Q inside the catalytic site of PDEs can utilize two distinct alignments